ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q1Subscription

Clinical Reviews in Bone and Mineral Metabolism

Acronym:crbm
•
Identifier (ISSN):1534-8644(Print)/1559-0119(Online)
•
Publisher:Springer Nature
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
5.7↑ +3.7
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Clinical Reviews in Bone and Mineral Metabolism

WoS Q1
03581.820230.82024220255.72026
Annual Impact Factor Metric
Current (2026):5.7
Scopus SJR & Rank
N/A

SCImago Journal Rank citation prestige weighting

Scopus / Elsevier Data
H-Index (Hirsch Index)
N/A

papers with at least that number of citations each

WoS: ESCIQ1
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessSubscription
5articles/year
0% Gold OA•0% Original Research

Aims & Scope

Clinical Reviews in Bone and Mineral Metabolism is an international review journal aimed at integrating new information from both basic and clinical science into the context of clinical practice in the wide field of Bone and Mineral Metabolism. Although one purpose of the journal is to deal with the well-known classical aspects of bone and mineral physiology, the journal’s unique character is to highlight information about the advancing field of molecular medicine, which now finds linkages between this classical field and disease states that in the past were considered distinct. For example, cardiovascular disease and osteoporosis share many biochemical pathways. New molecular tools show common pathways with bone physiology and obesity, diabetes mellitus, and energy metabolism. The focus on the novel is a major aspect of this journal’s purpose. The rapid developments in the field needs to be represented in a comprehensive way in order to keep students, clinicians and researchers up-to date. In order to assure that all latest developments are covered, the journal publishes, not only, unsolicited reviews, but also invited reviews on most important topics as well.

Topics Covered (Recognized by AI)
Medicine99.1%Internal medicine91.9%Biology86.4%Endocrinology69.7%Pathology68.4%Psychology67.2%Psychiatry60.5%Genetics55.9%Radiology54.5%Chemistry47.6%Rheumatology43.9%Osteoporosis40.6%Biochemistry38.8%Surgery35.1%Physics23.8%Bone remodeling23.1%Anatomy22.9%Organic chemistry22.4%Bone mineral20.6%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

ENDOCRINOLOGY & METABOLISM

Q1
Rank35/198
IndexESCI
JCIESCI2026

ENDOCRINOLOGY & METABOLISM

Q4
Rank167/198
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

15 year
2026Latest
IF5.7
Articles / Year—
Total Citations—
2025
IF2
Articles / Year—
Total Citations—
2024
IF0.8
Articles / Year—
Total Citations—
2023
IF1.8
Articles / Year3
Total Citations40
2022
IF—
Articles / Year3
Total Citations9

SCImago & Scopus Journal Intelligence

Not indexed in SCImago / Scopus database

This journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ENDOCRINOLOGY & METABOLISM
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Clinical Reviews in Bone and Mineral Metabolism (acronym: crbm, ISSN: 1534-8644) is a peer-reviewed international scholarly journal in the field of ENDOCRINOLOGY & METABOLISM, published by Springer Nature in United States. The periodical holds a Journal Impact Factor (JIF) of 5.70, ranking in quartile Q1 of Web of Science (ESCI).

The journal enforces rigorous peer evaluation with a publication frequency of 4 issues per year, an annual output of approximately 5 scientific articles. In terms of accessibility and author fees, it operates under the Subscription model with APC fees are not specified. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Subscription
Publisher
Springer Nature
Publication Language
English
Frequency
4 issues per year
Indexing & Databases
ESCIScopusPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: e1a83731-96fe-4afe-9b37-c6eca0f9d73c
Database Updated: 2026-10-01